Research-based synthesized Action Plan • Not an official Cardinal Health publication
Page 1
CARDINAL HEALTH
Cardinal Health’s Specialty Market Expansion
and at-Home Healthcare Integration Action
Plan
Strategic Execution Framework • FY2026–FY2028
EXECUTIVE FOUNDATION
Cardinal Health is executing a growth strategy that combines its scale in pharmaceutical distribution with higher-growth specialty and
at-home healthcare businesses. The company’s current portfolio emphasizes specialty pharmaceutical distribution and services, oncology
and other physician-practice platforms, at-Home Solutions, nuclear pharmacy, and logistics capabilities.
The latest FY2026 results and FY2027 guidance show the strategy moving from portfolio assembly toward operating execution. Cardinal
Health reported FY2026 revenue of approximately $254.4 billion and FY2026 non-GAAP diluted EPS of $10.90. Management’s FY2027
outlook calls for non-GAAP diluted EPS of $12.40–$12.60, approximately $700 million of capital expenditures, and adjusted free cash flow
of $3.5–$4.0 billion.
SPECIALTY ENGINE
Cardinal Health has identified specialty as a major growth platform. At its January 2026 investor presentation, the company highlighted a
Specialty business exceeding $50 billion in revenue and approximately 16% three-year CAGR. Its specialty strategy spans oncology,
urology, autoimmune and other complex therapies, physician-practice relationships, and biopharma services.
AT-HOME ENGINE
At-Home Solutions is being expanded through direct-to-patient capabilities and targeted acquisitions. Cardinal Health has used the
Advanced Diabetes Supply platform as a foundation and in 2026 announced additional tuck-in transactions involving AdaptHealth’s
Diabetes Health business and Strive Medical. The ContinuCare Pathway further connects retail-pharmacy referrals with home delivery of
eligible diabetes supplies.
OPERATING ENGINE
The action plan connects growth investments to distribution modernization. Cardinal Health’s Consumer Health Logistics Center and
planned Indianapolis distribution center provide physical infrastructure for higher-volume, more automated fulfillment, while Velocare
extends logistics capabilities into hospital-at-home care.
$50B+
16%
$12.40–$12.60
2027
Specialty revenue
scale
Specialty 3-year
CAGR
FY2027 non-GAAP
EPS guidance
Indianapolis DC
planned opening
STRATEGIC OBJECTIVE
Expand Cardinal Health’s specialty and at-home platforms while integrating acquisitions, referral pathways, advanced fulfillment, and
capital discipline into a scalable healthcare-services network.
INTEGRITY NOTE:
This is a research-based synthesized Action Plan. It is not an official Cardinal Health publication and does not imply company endorsement.
Research-based synthesized Action Plan • Not an official Cardinal Health publication
Page 2
1. Strategic Priorities & Current-State Baseline
Specialty Market Expansion
Grow higher-value specialty distribution and services, with emphasis on oncology, urology, multispecialty physician platforms, biopharma
services, and complex therapies.
At-Home Healthcare Integration
Expand direct-to-patient fulfillment for chronic-care supplies and medical products while integrating acquired diabetes, urology, wound-care
and ostomy capabilities.
Pharmacy-to-Home Connectivity
Use ContinuCare Pathway and retail relationships to simplify referrals, eligibility, fulfillment and patient communication.
Distribution Modernization
Increase automation, throughput, inventory visibility and network flexibility through the Consumer Health Logistics Center and the
Indianapolis facility.
Hospital-at-Home Logistics
Use Velocare to support rapid deployment, replenishment, retrieval and logistics for hospital-at-home programs.
Capital & Portfolio Discipline
Prioritize acquisitions and infrastructure that strengthen strategic capabilities, deliver attractive returns and can be integrated without
compromising service quality.
2. Verified Baseline
Area
Verified current position
Execution implication
Specialty
>$50B revenue scale; ~16% three-year CAGR highlighted in Jan. 2026 strategy update
Protect specialty growth while expanding differentiated platforms
FY2027 outlook
Non-GAAP EPS $12.40–$12.60; CapEx ~ $700M; adjusted FCF $3.5–$4.0B
Fund growth while retaining financial flexibility
At-Home
Advanced Diabetes Supply foundation plus 2026 tuck-in acquisitionsIntegrate assets into a coherent direct-to-patient platform
ContinuCare
Pathway launched with retail-pharmacy partnership including PublixIncrease referral conversion and reduce fulfillment friction
Indianapolis DC
New automated distribution center planned for 2027
Add capacity, robotics and network flexibility
Consumer Health Logistics Center
Opened to improve responsiveness to demand changes
Use as an operating benchmark for automation and replenishment
Research-based synthesized Action Plan • Not an official Cardinal Health publication
Page 3
3. Comprehensive Execution Framework
A. Specialty Platform Expansion
Prioritize oncology, urology and multispecialty opportunities where Cardinal can combine distribution, practice services, clinical research,
data and biopharma relationships. Use standardized integration playbooks for acquired or affiliated platforms.
B. At-Home Portfolio Integration
Unify diabetes, urology, wound-care and ostomy capabilities under a common operating model. Map patient journeys from referral through
eligibility, fulfillment, delivery, reorder and support.
C. ContinuCare Referral Flywheel
Expand pharmacy referral relationships, standardize referral data and automate handoffs. Track referral acceptance, conversion, fulfillment
time, reorder behavior and patient experience.
D. Velocare Hospital-at-Home Network
Develop repeatable logistics packages for hospital-at-home customers: equipment staging, delivery, setup, retrieval and reverse logistics.
Establish service-level metrics before geographic expansion.
E. Automated Distribution
Use the Indianapolis facility as a flagship automation program. Coordinate robotics, warehouse-management systems, inventory controls,
workforce training and exception management before scaling lessons across the network.
F. Inventory & Supply Resilience
Increase visibility for specialty products and home-care supplies; segment inventory by clinical criticality, demand volatility and lead time;
use contingency sourcing and safety-stock policies where justified.
G. Integration Office
Create cross-functional integration plans for every transaction covering technology, contracts, workforce, regulatory requirements, quality,
patient communications, finance and synergy tracking.
H. Capital Allocation
Evaluate each growth investment on strategic fit, cash returns, integration complexity, service impact and downside scenarios. Maintain
disciplined repurchases alongside growth investment.
4. Responsible Teams & Decision Rights
Pharmaceutical & Specialty Solutions
Specialty distribution, physician platforms, biopharma relationships and commercial growth.
at-Home Solutions
Home medical supply operations, patient fulfillment, acquisition integration and direct-to-patient experience.
Velocare / Hospital-at-Home Logistics
Equipment logistics, deployment, retrieval and healthcare-provider service operations.
Supply Chain & Logistics
Distribution-center design, automation, inventory, transportation and network optimization.
Technology & Digital
ContinuCare workflows, data integration, warehouse systems, analytics and cybersecurity.
Finance / Corporate Development
Acquisition underwriting, capital allocation, integration economics and portfolio returns.
Quality / Regulatory / Compliance
Patient safety, healthcare regulations, product controls, privacy and transaction compliance.
Research-based synthesized Action Plan • Not an official Cardinal Health publication
Page 4
5. Action Plan Timeline & Milestones
FY2026
Portfolio acceleration
Execute and integrate announced at-Home tuck-ins; strengthen specialty platforms; scale ContinuCare relationships; prepare
Integration plans approved; referral funnel mea
FY2026 H2
Operating integration
Unify patient journeys, technology interfaces, inventory policies and customer-service workflows across at-Home businesses.
Common operating KPIs; reduced handoff friction;
FY2027
Automation & network expansionBring Indianapolis distribution center online; use advanced automation to increase capacity, consistency and workforce productivity.
Facility ramp milestones; throughput and service-le
FY2027
Specialty growth optimization
Expand oncology/urology/multispecialty capabilities and biopharma services while preserving clinical and customer quality.
Growth and margin targets; platform utilization and
FY2028
Network maturation
Scale proven at-home, hospital-at-home and specialty workflows into additional markets based on unit economics and service perform
Portfolio-level return review; expansion gates appli
6. KPI Scorecard
KPI
Leading measures
Outcome / guardrail
Specialty growth
Revenue growth, platform additions, customer retention
Sustainable specialty growth and margin quality
At-home growth
Active patients, referral conversion, reorder rate
Revenue growth, service quality and patient retention
Referral efficiency
ContinuCare referrals, acceptance, fulfillment cycle
Higher conversion; fewer manual handoffs
Distribution
Orders/hour, automation utilization, inventory accuracy
Service levels, productivity and cost per order
Hospital-at-home
Deployments, retrieval cycle, SLA performance
Provider satisfaction; safe and reliable logistics
Integration
Synergy realization, system migration, employee retention
Acquisition value capture without service disruption
Capital
CapEx, acquisition spend, FCF, returns
Disciplined capital deployment and liquidity
Research-based synthesized Action Plan • Not an official Cardinal Health publication
Page 5
7. Risks, Dependencies & Mitigation
Acquisition integration
Multiple businesses can create duplicated systems, processes and customer handoffs.
Use 100-day plans, common data architecture, integration owners and staged syne
Specialty concentration
Growth in complex therapies can increase exposure to pricing, reimbursement and product volatility.
Diversify across therapy areas and services; monitor margin and working-capital sensitivi
Patient-service disruption
Technology or operating changes can interrupt home fulfillment.
Parallel-run critical workflows, maintain escalation paths and monitor service-level except
Automation ramp
New robotics and warehouse systems may underperform during commissioning.
Stage go-live, retain manual contingencies, train operators and use throughput/accuracy
Supply disruption
Specialty and home-care products can face shortages or allocation constraints.
Segment critical SKUs, strengthen visibility, qualify alternates and use targeted safety sto
Regulatory / privacy
Healthcare data, medical products and patient interactions carry high compliance requirements.
Embed regulatory review, privacy controls and quality checks into every workflow.
Capital discipline
Acquisition and infrastructure spending can dilute returns if growth assumptions weaken.
Use hurdle rates, scenario testing, integration milestones and portfolio review gates.
8. Action
→
Impact Model
Specialty platform expansion
More differentiated services
→
deeper provider/biopharma relationships
→
higher-value growth and stronger strategic positioning.
At-home acquisitions
Broader patient/product coverage
→
greater direct-to-patient density
→
improved scale and cross-platform operating leverage.
ContinuCare
Simpler pharmacy referral
→
faster patient handoff
→
higher fulfillment conversion and stronger retail-provider relationships.
Automated Indianapolis distribution
Higher automation and throughput
→
greater capacity and consistency
→
improved network economics as volumes scale.
Velocare logistics
Repeatable hospital-at-home logistics
→
lower operational friction for providers
→
broader adoption of home-based care models.
Integrated governance
Unified financial, operational and clinical KPIs
→
earlier exception detection
→
better capital and service decisions.
9. Progress-Tracking Cadence
Weekly:
integration exceptions, patient-service issues, facility commissioning and critical supply constraints.
Monthly:
specialty growth,
at-home volumes, referral conversion, distribution productivity and capital spend.
Quarterly:
executive portfolio review, acquisition
synergies, returns, service quality and expansion gates.
Annually:
refresh market assumptions, portfolio priorities, capital allocation and
strategic milestones.
Research-based synthesized Action Plan • Not an official Cardinal Health publication
Page 6
10. Research Basis & Executive Conclusion
This document synthesizes Cardinal Health’s latest publicly disclosed strategic priorities, transactions, operating initiatives and FY2027
financial guidance into an execution framework. It deliberately distinguishes verified company facts from recommended planning
mechanisms.
Verified evidence used
• Cardinal Health’s August 11, 2026 FY2026 results reported FY2026 revenue of approximately $254.4B and non-GAAP diluted EPS of
$10.90, with FY2027 non-GAAP diluted EPS guidance of $12.40–$12.60.
• Cardinal Health’s January 2026 J.P. Morgan Healthcare Conference materials highlighted Specialty revenue above $50B and
approximately 16% three-year CAGR as a major strategic growth engine.
• Cardinal Health announced 2026 tuck-in acquisitions involving AdaptHealth’s Diabetes Health business and Strive Medical to expand
At-Home Solutions.
• ContinuCare Pathway was presented as a pharmacy-to-home solution, including a partnership with Publix, designed to simplify diabetes
medical-supply fulfillment.
• Cardinal Health has described its Consumer Health Logistics Center as a major network capability and its Indianapolis distribution center
as an advanced automation project planned for 2027.
• Cardinal Health’s Velocare business supports hospital-at-home logistics, including equipment delivery, setup and retrieval for healthcare
providers.
Source set
Primary sources: Cardinal Health Newsroom — FY2026 Results & FY2027 Guidance (Aug. 11, 2026); Cardinal Health — J.P. Morgan Healthcare Conference strategic
update (Jan. 13, 2026); Cardinal Health Newsroom — ContinuCare and independent-pharmacy strategy materials; Cardinal Health FY2025 Sustainable Business
Report; Cardinal Health materials on At-Home Solutions, Velocare and distribution modernization.
FINAL EXECUTIVE TAKEAWAY
Cardinal Health’s current opportunity is to turn specialty scale and at-home reach into an integrated healthcare-services platform. The
highest-value execution path is not simply acquiring more assets; it is
integrating patient journeys, specialty capabilities, referral
workflows, automated fulfillment and disciplined capital allocation
so each additional platform strengthens the economics and
resilience of the broader network.
Research-based synthesized Action Plan • Not an official Cardinal Health publication • Prepared September 2026
